Re Contract

NMT Group PLC
26 September 2001

September 26, 2001

NMT Announces Strategic Contract Award With Broadlane Inc.

New Medical Technology Inc. (NMT Inc.), the manufacturer of retractable needle
devices to prevent needlestick injuries, announced today the award of a
purchasing contract, with Broadlane Inc, of  Dallas Texas.

Broadlane, formerly the corporate procurement division of Tenet Healthcare, is
one of the fastest growing Group Purchasing Organisations  (GPOs) in the
United States, as well as a provider of other supply chain management
solutions to healthcare facilities and suppliers.  Broadlane members include
more than 568 hospital and 2164 sub-acute healthcare facilities. Members
participating in this contract award include Tenet Healthcare, Kaiser
Permanente, Continuum Healthcare Partners, Community Health Systems, IASIS
Healthcare and Universal Health Services.

Under the terms of the contract NMT will supply Broadlane member facilities
with its patented, latex-free NMT safety syringe. The NMT safety syringe
features automatic needle retraction technology that is activated as the user
depresses the plunger to inject medication.  After having been automatically
retracted, the needle is safely stored in the barrel after use, virtually
eliminating needlestick injuries. The NMT safety syringe will be provided to
Broadlane in both its 3cc and 1cc sizes.

It is estimated that, every day, healthcare workers in the United States
experience nearly 3,000 inadvertent needlesticks. On November 6, 2000,
President Clinton signed the Federal Needlestick Safety and Prevention Act
into law, after unanimous approval in Congress. This law mandates that health
care workers have access to safety-engineered sharps devices that provide
added protection against needlesticks and consequential disease transmission
due to bloodborne pathogens such as HIV/AIDS.

Commenting, Stephen J. Czick, President of NMT Inc.,said: 'We are very pleased
that Broadlane has chosen the NMT safety syringe as part of its strategy to
provide safety devices to its members which prevent needlestick injuries. This
is another successful contract win from our growing US sales team and will
help to facilitate NMT's growth strategy in the important US market.  We
believe that the automatic needle retraction technology contained in the NMT
safety syringe is the ultimate in needlestick prevention and we continue to
see strong interest, evaluation and usage of our products throughout the
United States.'

Enquiries:

NMT Group PLC

Roy Smith, Chief Executive Officer                       02380 646 783
Gerard Cassels, Finance Director                         01506 445 000

NMT Inc.
Stephen J. Czick, President                       001 617 852 4396

Financial Dynamics
David Yates/Fiona Noblet                           020 7831 3113